OII insider filing: 14,840 vested shares to be sold via Fidelity on NYSE
Rhea-AI Filing Summary
Oceaneering International (OII) filed a Form 144 reporting a proposed sale of 14,840 common shares, acquired on 02/26/2024 through restricted stock vesting as compensation. The sale is scheduled to occur on or about 08/27/2025 through Fidelity Brokerage Services LLC at an indicated aggregate market value of $361,473.66. The filing shows 100,207,596 shares outstanding, and the seller reports no sales in the past three months. The filer certifies no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale filing; small volume relative to outstanding shares, likely neutral for investors.
The Form 144 documents a proposed sale of 14,840 shares valued at $361,474, representing a very small fraction of the issuer's 100,207,596 shares outstanding (~0.015%). The shares were acquired via restricted stock vesting and designated as compensation, with the trade to be executed through Fidelity on the NYSE. There are no reported sales in the prior three months and the filer attests to absence of undisclosed material adverse information. Based solely on the filing, this appears to be an administrative disclosure of a planned sale rather than a material corporate event.
TL;DR: Compliance-focused disclosure; confirms insiders followed Rule 144 procedures for compensatory shares.
The notice specifies acquisition by restricted stock vesting and lists the planned sale date and broker, meeting procedural requirements for Rule 144 notifications. The filing includes the standard attestation regarding material information and indicates no recent sales, which aligns with routine governance and insider-trading disclosure practices. There is no evidence in the document of governance issues, unusual lock-up exceptions, or aggregated sales obligations that would raise immediate concern.